Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Option Care Health recently shared its third-quarter results for 2024.</li><li>The healthcare company reported encouraging outcomes, reflecting significant strides in revenue growth and improvements in gross profit.</li><li>The quarter was marked by double-digit top-line growth, propelled by organic growth initiatives.</li></ul>

Option Care Health recently shared its third-quarter results for 2024.The healthcare company reported encouraging outcomes, reflecting significant strides in revenue growth and improvements in gross profit.The quarter was marked by double-digit top-line growth, propelled by organic growth initiatives.

Option Care Health: Expansion into Acute Care and Specialty Infusion & Other Major Drivers

<ul><li>Option Care Health achieved notable results during the second quarter of 2024, demonstrating a solid performance amidst notable supply chain disruptions and a major cyberattack.</li><li>The company reported a revenue increase of 14.8% year-over-year, with growth balanced across their portfolio.</li><li>Particularly strong were newer limited distribution and rare orphan therapies within the chronic portfolio.</li></ul>

Option Care Health achieved notable results during the second quarter of 2024, demonstrating a solid performance amidst notable supply chain disruptions and a major cyberattack.The company reported a revenue increase of 14.8% year-over-year, with growth balanced across their portfolio.Particularly strong were newer limited distribution and rare orphan therapies within the chronic portfolio.

Option Care Health Inc.: How Are The Market & Socio-Demographic Trends Impacting Their Future Revenues? - Major Drivers

<ul><li>This is our first report on Option Care Health.</li><li>The company reported a decent set of Fourth Quarter 2023 Earnings.</li><li>They attribute a significant part of their growth to their commitment to offering innovative services aiming to improve patient outcomes and reduce costs.</li></ul>

This is our first report on Option Care Health.The company reported a decent set of Fourth Quarter 2023 Earnings.They attribute a significant part of their growth to their commitment to offering innovative services aiming to improve patient outcomes and reduce costs.

Option Care Health Inc.: Market Expansion Through Strategic Therapies & AI! - Major Drivers

Option Care Health Inc.: Initiation Of Coverage - Its Efficient Spending Through Technology and Automation Paying Off? - Major Drivers

United States

Option Care Health, Inc. provides infusion and home care management solutions. The Company offers products, services, and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders, and heart failures. Option Care Health serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Option Care Health (OPCH US)

Option Care Health: Expansion into Acute Care and Specialty Infusion & Other Major Drivers

Option Care Health recently shared its third-quarter results for 2024. The healthcare company reported encouraging outcomes, reflecting...

Baptista Research

Option Care Health Inc.: How Are The Market & Socio-Demographic Trends Impacting Their Future Revenues? - Major Drivers

Option Care Health achieved notable results during the second quarter of 2024, demonstrating a solid performance amidst notable supply chain...

Baptista Research

Option Care Health Inc.: Market Expansion Through Strategic Therapies & AI! - Major Drivers

This is our first report on Option Care Health. The company reported a decent set of Fourth Quarter 2023 Earnings. They attribute a significant...

Baptista Research

Option Care Health Inc.: Initiation Of Coverage - Its Efficient Spending Through Technology and Automation Paying Off? - Major Drivers

This is our first report on Option Care Health. The company reported a decent set of Fourth Quarter 2023 Earnings. They attribute a significant...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)